NYSE:TEVA - Teva Pharmaceutical Industries Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $17.40 -0.62 (-3.44 %) (As of 02/20/2019 04:00 PM ET)Previous Close$18.02Today's Range$17.3650 - $18.0552-Week Range$14.59 - $25.96Volume14.00 million shsAverage Volume10.56 million shsMarket Capitalization$17.69 billionP/E Ratio6.21Dividend YieldN/ABeta1.46 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Teva Pharmaceutical Industries (NYSE:TEVA) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.20 Wall Street analysts have issued ratings and price targets for Teva Pharmaceutical Industries in the last 12 months. Their average twelve-month price target is $22.0667, suggesting that the stock has a possible upside of 26.82%. The high price target for TEVA is $30.00 and the low price target for TEVA is $12.00. There are currently 1 sell rating, 13 hold ratings, 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldHoldConsensus Rating Score: 2.302.302.182.00Ratings Breakdown: 1 Sell Rating(s)13 Hold Rating(s)5 Buy Rating(s)1 Strong Buy Rating(s)1 Sell Rating(s)13 Hold Rating(s)5 Buy Rating(s)1 Strong Buy Rating(s)2 Sell Rating(s)15 Hold Rating(s)4 Buy Rating(s)1 Strong Buy Rating(s)6 Sell Rating(s)14 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $22.0667$22.4776$22.2105$20.42Price Target Upside: 26.82% upside41.81% upside3.81% downside11.53% downsideTeva Pharmaceutical Industries (NYSE:TEVA) Consensus Price Target History Teva Pharmaceutical Industries (NYSE:TEVA) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails2/20/2019MizuhoDowngradeBuy ➝ Neutral$25.00 ➝ $18.00Medium2/14/2019Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$26.00 ➝ $20.00Medium2/14/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$22.00Medium2/14/2019Maxim GroupReiterated RatingHoldMedium2/14/2019Wells Fargo & CoReiterated RatingHold$24.00 ➝ $20.00Medium2/11/2019OppenheimerReiterated RatingHoldMedium2/5/2019HSBCSet Price TargetSell$12.00High2/5/2019Bank of AmericaReiterated RatingBuy$24.00Low1/23/2019Piper Jaffray CompaniesUpgradeUnderweight ➝ Neutral$15.00 ➝ $16.00Low1/23/2019UBS GroupUpgradeNeutral ➝ BuyLow11/5/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$20.00 ➝ $27.00Low11/2/2018Royal Bank of CanadaSet Price TargetHold$22.00Low10/1/2018Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$30.00High10/1/2018Leerink SwannUpgradeUnderperform ➝ Market Perform$16.00 ➝ $24.00High9/27/2018Cantor FitzgeraldReiterated RatingHold$25.00High9/21/2018CIBCReiterated RatingMarket Perform ➝ Market PerformLow9/17/2018BTIG ResearchUpgradeSell ➝ NeutralHigh8/3/2018Jefferies Financial GroupReiterated RatingHold$21.00Medium8/2/2018BarclaysSet Price TargetEqual Weight ➝ Hold$20.00 ➝ $23.00Medium6/27/2018CitigroupBoost Price TargetBuy$25.00 ➝ $27.00Medium2/9/2018Deutsche BankLower Price TargetHold ➝ Hold$20.00 ➝ $18.00Medium2/9/2018GabelliDowngradeBuy ➝ Hold$19.00Medium1/25/2018Susquehanna BancsharesReiterated RatingPositive ➝ Positive$22.00 ➝ $24.00Medium12/12/2017GuggenheimInitiated CoverageNeutral ➝ Neutral$16.00High11/13/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$11.48 ➝ $11.00N/A10/25/2017Evercore ISISet Price TargetBuy$38.00N/A10/4/2017CowenReiterated RatingMarket Perform$30.00 ➝ $18.00N/A9/21/2017Sanford C. BernsteinLower Price TargetMkt Perform ➝ Market Perform$28.00 ➝ $20.00Low9/6/2017JMP SecuritiesBoost Price TargetUnderperform$13.00 ➝ $14.00Low2/28/2017ArgusDowngradeBuy ➝ Hold$59.35 ➝ $31.90N/A(Data available from 2/20/2017 forward) This page was last updated on 2/20/2019 by MarketBeat.com StaffFeatured Article: What are different types of coverage ratios?